Donenberg Phillip B. 4
4 · Tectonic Therapeutic, Inc. · Filed Jun 10, 2026
Research Summary
AI-generated summary of this filing
Tectonic Therapeutic Director Phillip Donenberg Receives 10,200-Share Award
What Happened
Phillip B. Donenberg, a director of Tectonic Therapeutic, was granted a derivative award of 10,200 shares on 2026-06-09. The filing lists an acquisition price of $0.00 (no cash paid) and a total reported value of $0. This is an award/grant (not a sale or open‑market purchase) and represents a right to receive shares in the future subject to vesting.
Key Details
- Transaction date: 2026-06-09; Form 4 filed 2026-06-10 (timely filing).
- Transaction type: Award/Grant of a derivative (code A); 10,200 shares acquired at $0.00.
- Shares owned after transaction: not specified in the public Form 4 disclosure.
- Vesting note: the award vests in full on the earliest of (i) June 9, 2027, (ii) the issuer’s 2027 Annual Meeting, or (iii) a Change in Control, provided Donenberg continues service (per footnote).
- No indication of tax withholding, immediate exercise, sale, or cashless transaction in the filing.
Context
A derivative award generally means the insider received rights to future stock (e.g., options or RSUs) rather than buying shares outright. Because this is a grant, it is not an immediate bullish purchase signal—it’s part of compensation and tied to future vesting and service requirements.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-06-09+10,200→ 10,200 totalExercise: $28.56Exp: 2036-06-08→ Common Stock (10,200 underlying)
Footnotes (1)
- [F1]The option shall vest in full on the earliest of (i) June 9, 2027, (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, or (iii) a "Change in Control" (as defined in the Issuer's 2024 Equity Incentive Plan) of the Issuer, subject in each case, to the Reporting Person providing continuous service to the Issuer on each such date.